https://scholars.lib.ntu.edu.tw/handle/123456789/630068
Title: | Pembrolizumab or pembrolizumab plus chemotherapy versus standard of care chemotherapy in patients with advanced gastric or gastroesophageal junction adenocarcinoma: Asian subgroup analysis of KEYNOTE-062 | Authors: | Satake, Hironaga Lee, Keun-Wook Chung, Hyun Cheol Lee, Jeeyun Yamaguchi, Kensei Chen, Jen-Shi Yoshikawa, Takaki Amagai, Kenji KUN-HUEI YEH Goto, Masahiro Chao, Yee Lam, Ka-On Han, Shi Rong Shiratori, Shinichi Shah, Sukrut Shitara, Kohei |
Keywords: | Asian patients; chemotherapy; gastric cancer; gastrooesophageal junction cancer; pembrolizumab | Issue Date: | 7-Mar-2023 | Publisher: | OXFORD UNIV PRESS | Journal Volume: | 53 | Journal Issue: | 3 | Start page/Pages: | 221 | Source: | Japanese journal of clinical oncology | Abstract: | First-line pembrolizumab with/without chemotherapy versus chemotherapy was evaluated in programmed death ligand 1 combined positive score ≥1, locally advanced/unresectable or metastatic gastric cancer/gastrooesophageal junction cancer in the KEYNOTE-062 study. We present results for patients enrolled in Asia. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/630068 | ISSN: | 0368-2811 | DOI: | 10.1093/jjco/hyac188 |
Appears in Collections: | 腫瘤醫學研究所 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.